Related Experiment Videos
Human tryptamine metabolism decreases during night sleep
Brain Research Bulletin
|January 1, 1983
Summary
Human sleep may decrease peripheral tryptamine activity. This study found that indoleacetic acid (IAA) levels change with sleep-wake cycles, while tryptamine (T) metabolism appears reduced during sleep.
Area of Science:
- Neuroscience
- Biochemistry
- Sleep Science
Background:
- Tryptamine and its metabolite indoleacetic acid (IAA) are involved in various physiological processes.
- Understanding the relationship between sleep, wakefulness, and neurochemical metabolism is crucial for sleep science.
Purpose of the Study:
- To investigate the impact of sleep and wakefulness on the utilization of tryptamine.
- To determine if behavioral state (sleep vs. wake) influences tryptamine and IAA levels.
Main Methods:
- Collected urine samples from 14 healthy male volunteers every 4 hours.
- Quantified urinary tryptamine (T) and indoleacetic acid (IAA) using fluorometric and spectrophotometric methods.
Main Results:
- Urinary IAA levels increased during the day and decreased during sleep, indicating behavioral state influences IAA levels more than circadian rhythms.
- Urinary Tryptamine (T) levels progressively increased throughout the day and continued to rise during the night.
- The ratio of IAA to T (IAA/T) decreased during sleep, suggesting reduced tryptamine metabolism.
Conclusions:
- Human sleep is associated with diminished peripheral tryptamine activity.
- Behavioral state, specifically sleep, significantly impacts the metabolism of tryptamine and its related compounds.